Sensible MedicineThis Fortnight in Medicine XXIX29711×0:00Current time: 0:00 / Total time: -37:28-37:28Audio playback is not supported on your browser. Please upgrade.This Fortnight in Medicine XXIXTreating MSSA and a new way to treat HFrEF (not really)Adam Cifu, MD, John Mandrola, and Andrew J FoyJul 01, 20262971ShareTranscriptCefazolin for Methicillin-Susceptible Staphylococcus aureus BacteremiaStopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysisThe Impact of Midodrine on Guideline-Directed Medical Therapy in Patients Admitted With Systolic Heart FailureDiscussion about this episodeCommentsRestacksSensible Medicine reply rulesSensible MedicineCommon sense and original thinking in bio-medicine A platform for diverse views and debateCommon sense and original thinking in bio-medicine A platform for diverse views and debateSubscribeListen onSubstack AppRSS FeedAppears in episodeAndrew J FoyWrites Andrew J Foy SubscribeAdam Cifu, MDJohn MandrolaRecent EpisodesThis Fortnight in Medicine XXXIVSep 23 • Adam Cifu, MD, Vinay Prasad MD MPH, and John MandrolaLecture 8 - endpointsSep 22 • Vinay Prasad MD MPHLecture 7Sep 15 • Vinay Prasad MD MPHFortnight in medicineSep 9 • Vinay Prasad MD MPHLecture 6 KM CurvesSep 8 • Vinay Prasad MD MPHLecture 5Sep 1 • Vinay Prasad MD MPHThis Fortnight in Medicine XXXIIIAug 26 • Adam Cifu, MD, John Mandrola, and Andrew J FoyLecture 4 - How not to be fooledAug 25 • Vinay Prasad MD MPH